Clinical trials
Strabismus trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
56 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 32 |
| Unknown status | 15 |
| Not yet recruiting | 8 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Minia University | 5 |
| Cairo University | 4 |
| Inje University | 3 |
| Tanta University | 3 |
| Universitat Politècnica de Catalunya | 3 |
| Assiut University | 2 |
| Foundation University Islamabad | 2 |
| Jaeb Center for Health Research | 2 |
| Yonsei University | 2 |
| Amany Refaat Mohamed Abdel Wahid | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Strabismus | 56 |
| Amblyopia | 15 |
| Exotropia | 9 |
| Anisometropia | 5 |
| Esotropia | 4 |
| Postoperative Nausea and Vomiting | 3 |
| Emergence Delirium | 2 |
| Abducens Nerve Diseases | 1 |
| Ataxia | 1 |
| Bites and Stings | 1 |
Trials
Showing 76 to 56 of 56. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.